Low-dose salinomycin induces anti-leukemic responses in AML and MLL

Development of anti-cancer drugs towards clinical application is costly and inefficient. Large screens of drugs, efficacious for non-cancer disease, are currently being used to identify candidates for repurposing based on their anti-cancer properties. Here, we show that low-dose salinomycin, a cocci...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncotarget
Huvudupphovsmän: Roulston, Gary D.R., Burt, Charlotte L., Kettyle, Laura M.J., Matchett, Kyle B., Keenan, Heather L., Mulgrew, Nuala M., Ramsey, Joanne M., Dougan, Caoifa, McKiernan, John, Grishagin, Ivan V., Mills, Ken I., Thompson, Alexander
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2016
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5341990/
https://ncbi.nlm.nih.gov/pubmed/27612428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11866
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk